These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52 related articles for article (PubMed ID: 7852499)
1. Identification and characterization of opioid-binding sites present in the Ishikawa human endometrial adenocarcinoma cell line. Hatzoglou A; Gravanis A; Margioris AN; Zoumakis E; Castanas E J Clin Endocrinol Metab; 1995 Feb; 80(2):418-23. PubMed ID: 7852499 [TBL] [Abstract][Full Text] [Related]
2. The antiproliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptors. Hatzoglou A; Bakogeorgou E; Castanas E Eur J Pharmacol; 1996 Jan; 296(2):199-207. PubMed ID: 8838457 [TBL] [Abstract][Full Text] [Related]
3. Kappa1-opioid binding sites are the dominant opioid binding sites in surgical specimens of human pheochromocytomas and in a human pheochromocytoma (KAT45) cell line. Kampa M; Margioris AN; Hatzoglou A; Dermitzaki I; Denizot A; Henry JF; Oliver C; Gravanis A; Castanas E Eur J Pharmacol; 1999 Jan; 364(2-3):255-62. PubMed ID: 9932731 [TBL] [Abstract][Full Text] [Related]
4. Opioid binding to rat and guinea-pig neural membranes in the presence of physiological cations at 37 degrees C. Werling LL; Zarr GD; Brown SR; Cox BM J Pharmacol Exp Ther; 1985 Jun; 233(3):722-8. PubMed ID: 2989494 [TBL] [Abstract][Full Text] [Related]
5. Kappa opioids and TGFbeta1 interact in human endometrial cells. Chatzaki E; Margioris AN; Makrigiannakis A; Castanas E; Georgoulias V; Gravanis A Mol Hum Reprod; 2000 Jul; 6(7):602-9. PubMed ID: 10871647 [TBL] [Abstract][Full Text] [Related]
6. Sodium regulation of agonist binding at opioid receptors. II. Effects of sodium replacement on opioid binding in guinea pig cortical membranes. Werling LL; Brown SR; Puttfarcken P; Cox BM Mol Pharmacol; 1986 Aug; 30(2):90-5. PubMed ID: 3016504 [TBL] [Abstract][Full Text] [Related]
7. Binding properties of C-truncated delta opioid receptors. Wang CH; Zhou DH; Chen J; Li GE; Pei G; Chi ZQ Zhongguo Yao Li Xue Bao; 1997 Jul; 18(4):337-40. PubMed ID: 10072917 [TBL] [Abstract][Full Text] [Related]
8. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus. Meunier JC; Kouakou Y; Puget A; Moisand C Mol Pharmacol; 1983 Jul; 24(1):23-9. PubMed ID: 6306437 [TBL] [Abstract][Full Text] [Related]
9. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes. Tam SW; Liu-Chen LY J Pharmacol Exp Ther; 1986 Nov; 239(2):351-7. PubMed ID: 3021954 [TBL] [Abstract][Full Text] [Related]
10. Comparative pharmacological properties and functional coupling of mu and delta opioid receptor sites in human neuroblastoma SH-SY5Y cells. Kazmi SM; Mishra RK Mol Pharmacol; 1987 Jul; 32(1):109-18. PubMed ID: 3037297 [TBL] [Abstract][Full Text] [Related]
11. The corticotropin-releasing hormone (CRH) in normal and tumoral epithelial cells of human endometrium. Makrigiannakis A; Zoumakis E; Margioris AN; Theodoropoulos P; Stournaras C; Gravanis A J Clin Endocrinol Metab; 1995 Jan; 80(1):185-9. PubMed ID: 7829610 [TBL] [Abstract][Full Text] [Related]
12. High affinity binding and direct antiproliferative effects of luteinizing hormone-releasing hormone analogs in human endometrial cancer cell lines. Emons G; Schröder B; Ortmann O; Westphalen S; Schulz KD; Schally AV J Clin Endocrinol Metab; 1993 Dec; 77(6):1458-64. PubMed ID: 8263128 [TBL] [Abstract][Full Text] [Related]
13. Functional opioid receptor sites in human placentas. Belisle S; Petit A; Gallo-Payet N; Bellabarba D; Lehoux JG; Lemaire S J Clin Endocrinol Metab; 1988 Feb; 66(2):283-9. PubMed ID: 2892853 [TBL] [Abstract][Full Text] [Related]
14. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes. Puttfarcken P; Werling LL; Brown SR; Cote TE; Cox BM Mol Pharmacol; 1986 Aug; 30(2):81-9. PubMed ID: 3016503 [TBL] [Abstract][Full Text] [Related]
15. Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes. Emmerson PJ; Liu MR; Woods JH; Medzihradsky F J Pharmacol Exp Ther; 1994 Dec; 271(3):1630-7. PubMed ID: 7996478 [TBL] [Abstract][Full Text] [Related]
16. The occurrence of different kappa opioid receptors (K1 and K2) in frog (Rana esculenta) brain membranes. Benyhe S; Varga E; Borsodi A; Wollemann M Acta Physiol Hung; 1990; 76(4):291-4. PubMed ID: 1966577 [TBL] [Abstract][Full Text] [Related]
17. Further demonstration of kappa opioid binding sites in the brain: evidence for heterogeneity. Su TP J Pharmacol Exp Ther; 1985 Jan; 232(1):144-8. PubMed ID: 2856939 [TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of delta opioid binding sites in the bovine pineal. Aloyo VJ J Pharmacol Exp Ther; 1992 Jul; 262(1):292-7. PubMed ID: 1320688 [TBL] [Abstract][Full Text] [Related]
19. Opioid peptide receptor studies. 7. The methylfentanyl congener RTI-4614-4 and its four enantiomers bind to different domains of the rat mu opioid receptor. Lu YF; Xu H; Liu-Chen LY; Chen C; Partilla JS; Brine GA; Carroll FI; Rice KC; Lai J; Porreca F; Sadee W; Rothman RB Synapse; 1998 Feb; 28(2):117-24. PubMed ID: 9450512 [TBL] [Abstract][Full Text] [Related]
20. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans. Ananthan S; Kezar HS; Carter RL; Saini SK; Rice KC; Wells JL; Davis P; Xu H; Dersch CM; Bilsky EJ; Porreca F; Rothman RB J Med Chem; 1999 Sep; 42(18):3527-38. PubMed ID: 10479286 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]